Table I.
Performance of IL-6, MMP-8, and the MR score for the detection of intra-amniotic inflammation and infection (defined as AF WBC count >100 cells/mm3 and a positive AF culture, respectively) as originally reported in reference [197].
Biomarker | Intra-amniotic inflammation | Intra-amniotic infection | ||
---|---|---|---|---|
Sensitivity (%) [95% CI] | Specificity (%) [95% CI] | Sensitivity (%) [95% CI] | Specificity (%) [95% CI] | |
MR score ≥ 3 | 93.0 [84.1–97.4] | 92.4 [89.2–94.0] | 79.5 [68.4–87.8] | 85.6 [81.7–88.5] |
IL-6 >11.4 ng/mL | 45.0 [34.5–52.4] | 94.8 [91.2–97.4] | 45.2 [36.6–52.9] | 61.9 [44.7–77.3] |
MMP-8 >23 ng/mL | 92.9 [82.5–97.5] | 66.7 [62.9–68.3] | 90.7 [79.9–96.2] | 65.0 [61.3–67.0] |
MR score: Mass restricted score; IL-6: Interleukin 6; MMP-8: Matrix metalloproteinase 8. Source reference [197].